p24 antigen and HIV screening. 1992

J J Lefrère, and A M Courouce, and P Rouger, and N Duedari, and M H Elghouzzi

UI MeSH Term Description Entries
D008297 Male Males
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015492 AIDS Serodiagnosis Immunologic tests for identification of HIV (HTLV-III/LAV) antibodies. They include assays for HIV SEROPOSITIVITY and HIV SERONEGATIVITY that have been developed for screening persons carrying the viral antibody from patients with overt symptoms of AIDS or AIDS-RELATED COMPLEX. AIDS Serology,HIV Serodiagnosis,HTLV-III Serodiagnosis,HTLV-III Serology,Serodiagnosis, AIDS,Serodiagnosis, HIV,Serodiagnosis, HTLV-III,Serology, AIDS,Serology, HTLV-III,AIDS Serodiagnoses,HIV Serodiagnoses,HTLV III Serodiagnosis,HTLV III Serology,HTLV-III Serodiagnoses,Serodiagnoses, AIDS,Serodiagnoses, HIV,Serodiagnoses, HTLV-III,Serodiagnosis, HTLV III,Serology, HTLV III
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D016655 HIV Core Protein p24 A major core protein of the human immunodeficiency virus encoded by the HIV gag gene. HIV-seropositive individuals mount a significant immune response to p24 and thus detection of antibodies to p24 is one basis for determining HIV infection by ELISA and Western blot assays. The protein is also being investigated as a potential HIV immunogen in vaccines. HIV Major Core Protein p24,HIV gag Gene Product p24,HIV p24 Antigen,gag Protein p24, HIV,p24(HIV),HIV Protein p24,HTLV-III p24,p24 protein, Human Immunodeficiency Virus,HTLV III p24,p24 Antigen, HIV,p24, HIV Protein,p24, HTLV-III

Related Publications

J J Lefrère, and A M Courouce, and P Rouger, and N Duedari, and M H Elghouzzi
February 1992, Lancet (London, England),
J J Lefrère, and A M Courouce, and P Rouger, and N Duedari, and M H Elghouzzi
February 2001, The AIDS reader,
J J Lefrère, and A M Courouce, and P Rouger, and N Duedari, and M H Elghouzzi
January 2005, Methods in molecular biology (Clifton, N.J.),
J J Lefrère, and A M Courouce, and P Rouger, and N Duedari, and M H Elghouzzi
June 2013, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology,
J J Lefrère, and A M Courouce, and P Rouger, and N Duedari, and M H Elghouzzi
October 1992, Lancet (London, England),
J J Lefrère, and A M Courouce, and P Rouger, and N Duedari, and M H Elghouzzi
July 2007, Journal of virological methods,
J J Lefrère, and A M Courouce, and P Rouger, and N Duedari, and M H Elghouzzi
June 2000, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine,
J J Lefrère, and A M Courouce, and P Rouger, and N Duedari, and M H Elghouzzi
November 2017, Journal of virological methods,
J J Lefrère, and A M Courouce, and P Rouger, and N Duedari, and M H Elghouzzi
February 1999, Schweizerische medizinische Wochenschrift,
J J Lefrère, and A M Courouce, and P Rouger, and N Duedari, and M H Elghouzzi
May 1994, Medizinische Klinik (Munich, Germany : 1983),
Copied contents to your clipboard!